Cell-penetrating peptides can confer biological function: Regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides

Frankel, 1988, Cellular uptake of the tat protein from human immunodeficiency virus, Cell, 55, 1189, 10.1016/0092-8674(88)90263-2 Green, 1988, Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein, Cell, 55, 1179, 10.1016/0092-8674(88)90262-0 Fiocchi, 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, 115, 182, 10.1016/S0016-5085(98)70381-6 Busse, 1998, Inflammation in asthma: the cornerstone of the disease and target of therapy, J. Allergy Clin. Immunol., 102, S17, 10.1016/S0091-6749(98)70002-8 McInnes, 2007, Cytokines in the pathogenesis of rheumatoid arthritis, Nat. Rev. Immunol., 7, 429, 10.1038/nri2094 Feldmann, 1999, The role of cytokines in the pathogenesis of rheumatoid arthritis, Rheumatology (Oxford), 38, 3 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 Taylor, 2009, Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis, Nat. Rev. Rheumatol., 5, 578, 10.1038/nrrheum.2009.181 Maini, 2000, Anti-cytokine therapy for rheumatoid arthritis, Annu. Rev. Med., 51, 207, 10.1146/annurev.med.51.1.207 Eigler, 1997, Taming TNF: strategies to restrain this proinflammatory cytokine, Immunol. Today, 18, 487, 10.1016/S0167-5699(97)01118-3 Kinne, 2007, Cells of the synovium in rheumatoid arthritis. Macrophages, Arthritis Res. Ther., 9, 224, 10.1186/ar2333 Sanchez-Munoz, 2008, Role of cytokines in inflammatory bowel disease, World J. Gastroenterol., 14, 4280, 10.3748/wjg.14.4280 Roux, 2004, ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiol. Mol. Biol. Rev., 68, 320, 10.1128/MMBR.68.2.320-344.2004 Gaestel, 2006, MAPKAP kinases — MKs — two's company, three's a crowd, Nat. Rev. Mol. Cell Biol., 7, 120, 10.1038/nrm1834 Ono, 2000, The p38 signal transduction pathway: activation and function, Cell. Signal., 12, 1, 10.1016/S0898-6568(99)00071-6 Engel, 1995, MAPKAP kinase 2 is activated by heat shock and TNF-alpha: in vivo phosphorylation of small heat shock protein results from stimulation of the MAP kinase cascade, J. Cell. Biochem., 57, 321, 10.1002/jcb.240570216 Kayyali, 2002, Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2, J. Biol. Chem., 277, 42596, 10.1074/jbc.M205863200 Tilly, 1996, Hypo-osmotic cell swelling activates the p38 MAP kinase signalling cascade, FEBS Lett., 395, 133, 10.1016/0014-5793(96)01028-9 Belka, 1995, Interleukin (IL)-6 signaling leads to phosphorylation of the small heat shock protein (Hsp)27 through activation of the MAP kinase and MAPKAP kinase 2 pathway in monocytes and monocytic leukemia cells, Leukemia, 9, 288 Ahlers, 1994, Interleukin-3 and granulocyte-macrophage colony-stimulating factor induce activation of the MAPKAP kinase 2 resulting in in vitro serine phosphorylation of the small heat shock protein (Hsp 27), Blood, 83, 1791, 10.1182/blood.V83.7.1791.1791 Neininger, 2002, MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels, J. Biol. Chem., 277, 3065, 10.1074/jbc.C100685200 Hitti, 2006, Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element, Mol. Cell. Biol., 26, 2399, 10.1128/MCB.26.6.2399-2407.2006 Kostenko, 2009, Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology, Cell. Mol. Life Sci., 66, 3289, 10.1007/s00018-009-0086-3 Kotlyarov, 2002, Distinct cellular functions of MK2, Mol. Cell. Biol., 22, 4827, 10.1128/MCB.22.13.4827-4835.2002 Stokoe, 1992, Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins, FEBS Lett., 313, 307, 10.1016/0014-5793(92)81216-9 Hayess, 1997, Effect of protein kinase inhibitors on activity of mammalian small heat-shock protein (HSP25) kinase, Biochem. Pharmacol., 53, 1239, 10.1016/S0006-2952(96)00877-5 Ward, 2009, Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce, J. Pept. Sci., 15, 668, 10.1002/psc.1168 Seal, 2003, Physical polymer matrices based on affinity interactions between peptides and polysaccharides, Biomacromolecules, 4, 1572, 10.1021/bm0342032 Tyler-Cross, 1996, Structure–function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes, Arch. Biochem. Biophys., 334, 206, 10.1006/abbi.1996.0448 Ho, 2001, Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo, Cancer Res., 61, 474 Ward, 2011, Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions, J. Surg. Res., 169, e27, 10.1016/j.jss.2011.01.043 Lopes, 2009, Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor, Biochem. Biophys. Res. Commun., 382, 535, 10.1016/j.bbrc.2009.03.056 Lopes, 2010, A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model, J. Vasc. Surg., 52, 1596, 10.1016/j.jvs.2010.06.168 Kotlyarov, 1999, MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis, Nat. Cell Biol., 1, 94, 10.1038/10061 Alford, 2007, Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling, J. Biol. Chem., 282, 6232, 10.1074/jbc.M610987200 Chen, 1995, AU-rich elements: characterization and importance in mRNA degradation, Trends Biochem. Sci., 20, 465, 10.1016/S0968-0004(00)89102-1 Kotlyarov, 2002, Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?, Biochem. Soc. Trans., 30, 959, 10.1042/bst0300959 Lehner, 2002, Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection, J. Immunol., 168, 4667, 10.4049/jimmunol.168.9.4667 Winzen, 1999, The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism, EMBO J., 18, 4969, 10.1093/emboj/18.18.4969 Coxon, 2003, MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils, Cell. Signal., 15, 993, 10.1016/S0898-6568(03)00074-3 Winzen, 2007, Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets, Mol. Cell. Biol., 27, 8388, 10.1128/MCB.01493-07 Briata, 2005, p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts, Mol. Cell, 20, 891, 10.1016/j.molcel.2005.10.021 Hoffmann, 2002, Multiple control of interleukin-8 gene expression, J. Leukoc. Biol., 72, 847, 10.1189/jlb.72.5.847 Duchardt, 2007, A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic, 8, 848, 10.1111/j.1600-0854.2007.00572.x Brugnano, 2010, Cell penetrating peptides can exert biological activity: a review, BioMol. Concepts, 1, 109, 10.1515/bmc.2010.016